{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:40:33Z","timestamp":1790023233716,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-adherence of patients with vulvovaginal candidiasis (VVC) to treatment recommendations leads to treatment failure and recurrence of infection. Therefore, this qualitative study was conducted to identify barriers and facilitators\u00a0of observance of treatment among women afflicted with vulvovaginal candidiasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This qualitative study was conducted through 26 in-depth unstructured interviews with 24 patients and 2 gynecologists using purposeful sampling with maximum variation in Ahvaz, southwest Iran. Interviews were conducted in person at health centers and the gynecologist\u2019s offices. MAXQDA 10 software and conventional content analysis were used for data analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The findings showed barriers and facilitator\u00a0factors of adherence to treatment in women with VVC. Some of these factors lead to an increase in adherence to treatment, and others play the role of hindering factors. These factors were classified into two main categories: patients\u2019 beliefs and patients\u2019 fears and concerns.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results of this study showed that many of the behaviors of patients from the acceptance of the diagnosis process to treatment are rooted in the patient's beliefs and fears. Therefore, it seems necessary to design and carry out interventions based on the findings of this study, which can be used in the development of appropriate solutions, treatment guidelines, and adopting a policy for treatment adherence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-022-00938-y","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:02:39Z","timestamp":1671591759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study"],"prefix":"10.1186","volume":"27","author":[{"given":"Maryam","family":"Erfaninejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Salahshouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Amirrajab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"issue":"8","key":"938_CR1","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s10096-021-04199-1","volume":"40","author":"LC Pereira","year":"2021","unstructured":"Pereira LC, Correia AF, da Silva ZDL, de Resende CN, Brand\u00e3o F, Almeida RM, et al. Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence. Eur J Clin Microbiol Infect Dis. 2021;40(8):1681\u201393.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"938_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12905-019-0748-8","volume":"19","author":"J Yano","year":"2019","unstructured":"Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women\u2019s Health. 2019;19(1):48.","journal-title":"BMC Women\u2019s Health"},{"issue":"1","key":"938_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12879-020-04985-w","volume":"20","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zhu Y, Fan S, Liu X, Liang Y, Shan Y. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis. BMC Infect Dis. 2020;20(1):287.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"938_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/microorganisms8020144","volume":"8","author":"D Rosati","year":"2020","unstructured":"Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 2020;8(2):144.","journal-title":"Microorganisms"},{"issue":"1","key":"938_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","volume":"214","author":"JD Sobel","year":"2016","unstructured":"Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15\u201321.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"938_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12879-019-4736-2","volume":"20","author":"N Ghaddar","year":"2020","unstructured":"Ghaddar N, Anastasiadis E, Halimeh R, Ghaddar A, Dhar R, AlFouzan W, et al. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. BMC Infect Dis. 2020;20(1):32.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"938_CR7","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.1038\/s41598-019-44579-4","volume":"9","author":"SJ Jang","year":"2019","unstructured":"Jang SJ, Lee K, Kwon B, You HJ, Ko G. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans. Sci Rep. 2019;9(1):8121.","journal-title":"Sci Rep"},{"issue":"5","key":"938_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027489","volume":"9","author":"J L\u00edrio","year":"2019","unstructured":"L\u00edrio J, Giraldo PC, Amaral RL, Sarmento ACA, Costa APF, Gon\u00e7alves AK. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol. BMJ Open. 2019;9(5): e027489.","journal-title":"BMJ Open"},{"issue":"5","key":"938_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1525-1497.1998.00101.x","volume":"13","author":"PL Carr","year":"1998","unstructured":"Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med. 1998;13(5):335\u201346.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"938_CR10","first-page":"410","volume":"8","author":"A Rezaei-Matehkolaei","year":"2016","unstructured":"Rezaei-Matehkolaei A, Shafiei S, Zarei-Mahmoudabadi A. Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species. Iran J Microbiol. 2016;8(6):410\u20137.","journal-title":"Iran J Microbiol"},{"key":"938_CR11","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2147\/IDR.S175588","volume":"11","author":"F Qin","year":"2018","unstructured":"Qin F, Wang Q, Zhang C, Fang C, Zhang L, Chen H, et al. Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis. Infect Drug Resist. 2018;11:1893\u2013901.","journal-title":"Infect Drug Resist"},{"key":"938_CR12","first-page":"31","volume":"8","author":"JD Sobel","year":"2014","unstructured":"Sobel JD. Factors involved in the patient\u2019s choice of oral or vaginal treatment for vulvovaginal candidiasis. Patient Prefer Adherence. 2014;8:31\u20134.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"938_CR13","volume":"12","author":"N Kiasat","year":"2019","unstructured":"Kiasat N, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Hamidavi Mohamadpour K, Molavi S, Khoshayand N. Prevalence of vulvovaginal candidiasis in Ahvaz, Southwest Iran: a semi-large scale study. Jundishapur J Microbiol. 2019;12(3): e89815.","journal-title":"Jundishapur J Microbiol"},{"key":"938_CR14","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3389\/fmicb.2019.01678","volume":"10","author":"N Kiasat","year":"2019","unstructured":"Kiasat N, Rezaei-Matehkolaei A, Mahmoudabadi AZ. Microsatellite typing and antifungal susceptibility of Candida glabrata strains isolated from patients with Candida Vaginitis. Front Microbiol. 2019;10:1678.","journal-title":"Front Microbiol"},{"issue":"6","key":"938_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","volume":"42","author":"B Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905\u201327.","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"938_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12905-022-01973-x","volume":"22","author":"M Bradfield Strydom","year":"2022","unstructured":"Bradfield Strydom M, Walpola RL, McMillan S, Khan S, Ware RS, Tiralongo E. Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey. BMC Womens Health. 2022;22(1):384.","journal-title":"BMC Womens Health"},{"key":"938_CR17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/nop2.558","volume":"7","author":"F Mostafavi-Darani","year":"2020","unstructured":"Mostafavi-Darani F, Zamani-Alavijeh F, Mahaki B, Salahshouri A. Exploring the barriers of adherence to dietary recommendations among patients with type 2 diabetes: a qualitative study in Iran. Nurs Open. 2020;7:1735\u201345.","journal-title":"Nurs Open"},{"issue":"1","key":"938_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13030-020-00202-x","volume":"15","author":"F Mostafavi","year":"2021","unstructured":"Mostafavi F, Alavijeh FZ, Salahshouri A, Mahaki B. The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study. Biopsychosoc Med. 2021;15(1):1.","journal-title":"Biopsychosoc Med"},{"issue":"2","key":"938_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1471-0528.15854","volume":"127","author":"J Norenhag","year":"2020","unstructured":"Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus, and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2020;127(2):171\u201380.","journal-title":"BJOG"},{"issue":"1","key":"938_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12941-020-0347-4","volume":"19","author":"N Kalia","year":"2020","unstructured":"Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19(1):5.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"11","key":"938_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207953","volume":"13","author":"D Grace","year":"2018","unstructured":"Grace D, Gaspar M, Paquette R, Rosenes R, Burchell AN, Grennan T, et al. HIV-positive gay men\u2019s knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: a qualitative study. PLoS ONE. 2018;13(11): e0207953.","journal-title":"PLoS ONE"},{"issue":"2","key":"938_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"196","key":"938_CR23","first-page":"125","volume":"31","author":"M Rezapour","year":"2021","unstructured":"Rezapour M, Zarghami M, Sheikhmoonesi F. Psychological experience and needs of front-line nurses during COVID-19 outbreak in Iran: a qualitative study. J Mazandaran Univ Med Sci. 2021;31(196):125\u201335.","journal-title":"J Mazandaran Univ Med Sci"},{"key":"938_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8","volume-title":"Naturalistic inquiry","author":"YS Lincoln","year":"1985","unstructured":"Lincoln YS, Guba EG. Naturalistic inquiry. London: Sage; 1985."},{"issue":"6","key":"938_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"3","key":"938_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151794","volume":"11","author":"J Bilardi","year":"2016","unstructured":"Bilardi J, Walker S, McNair R, Mooney-Somers J, Temple-Smith M, Bellhouse C, et al. Women\u2019s management of recurrent bacterial vaginosis and experiences of clinical care: a qualitative study. PLoS ONE. 2016;11(3): e0151794.","journal-title":"PLoS ONE"},{"key":"938_CR27","volume-title":"StatPearls","author":"H Brock","year":"2021","unstructured":"Brock H, Hany M. Obsessive-Compulsive Disorder. In: Brock H, editor. StatPearls. Treasure Island: StatPearls Publishing; 2021."},{"key":"938_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.2602","author":"V Khosravani","year":"2021","unstructured":"Khosravani V, Samimi Ardestani SM, Sharifi Bastan F, McKay D, Asmundson GJG. The associations of obsessive-compulsive symptom dimensions and general severity with suicidal ideation in patients with obsessive-compulsive disorder: the role of specific stress responses to COVID-19. Clin Psychol Psychother. 2021. https:\/\/doi.org\/10.1002\/cpp.2602.","journal-title":"Clin Psychol Psychother"},{"issue":"5","key":"938_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/archdischild-2014-306934","volume":"100","author":"G Krebs","year":"2015","unstructured":"Krebs G, Heyman I. Obsessive-compulsive disorder in children and adolescents. Arch Dis Child. 2015;100(5):495\u20139.","journal-title":"Arch Dis Child"},{"key":"938_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.neubiorev.2016.09.025","volume":"71","author":"A P\u00e9rez-Vigil","year":"2016","unstructured":"P\u00e9rez-Vigil A, Fern\u00e1ndez de la Cruz L, Brander G, Isomura K, Gromark C, Mataix-Cols D. The link between autoimmune diseases and obsessive-compulsive and tic disorders: a systematic review. Neurosci Biobehav Rev. 2016;71:542\u201362.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"938_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4314\/ahs.v17i2.12","volume":"17","author":"ZB Khalesi","year":"2017","unstructured":"Khalesi ZB, Simbar M, Azin SA. A qualitative study of sexual health education among Iranian engaged couples. Afr Health Sci. 2017;17(2):382\u201390.","journal-title":"Afr Health Sci"},{"issue":"8","key":"938_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41593-019-0456-6","volume":"22","author":"D Mobbs","year":"2019","unstructured":"Mobbs D, Adolphs R, Fanselow MS, Barrett LF, LeDoux JE, Ressler K, et al. Viewpoints: approaches to defining and investigating fear. Nat Neurosci. 2019;22(8):1205\u201316.","journal-title":"Nat Neurosci"},{"issue":"11","key":"938_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224964","volume":"14","author":"J Anstey Watkins","year":"2019","unstructured":"Anstey Watkins J, Ross JDC, Thandi S, Brittain C, Kai J, Griffiths F. Acceptability of and treatment preferences for recurrent bacterial vaginosis-topical lactic acid gel or oral metronidazole antibiotic: qualitative findings from the VITA trial. PLoS ONE. 2019;14(11): e0224964.","journal-title":"PLoS ONE"},{"key":"938_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-020-00281-5","author":"CA Harper","year":"2020","unstructured":"Harper CA, Satchell LP, Fido D, Latzman RD. Functional fear predicts public health compliance in the COVID-19 pandemic. Int J Mental Health Addict. 2020. https:\/\/doi.org\/10.1007\/s11469-020-00281-5.","journal-title":"Int J Mental Health Addict"},{"key":"938_CR35","doi-asserted-by":"publisher","first-page":"113100","DOI":"10.1016\/j.psychres.2020.113100","volume":"289","author":"D Tzur Bitan","year":"2020","unstructured":"Tzur Bitan D, Grossman-Giron A, Bloch Y, Mayer Y, Shiffman N, Mendlovic S. Fear of COVID-19 scale: psychometric characteristics, reliability, and validity in the Israeli population. Psychiatry Res. 2020;289:113100.","journal-title":"Psychiatry Res"},{"key":"938_CR36","volume-title":"StatPearls","author":"A Bialy","year":"2022","unstructured":"Bialy A. Gynecologic examination. In: Bialy A, editor. StatPearls. Treasure Island: StatPearls Publishing; 2022."},{"key":"938_CR37","doi-asserted-by":"crossref","first-page":"215013272199219","DOI":"10.1177\/2150132721992195","volume":"12","author":"DJ O'Laughlin","year":"2021","unstructured":"O\u2019Laughlin DJ, Strelow B, Fellows N, Kelsey E, Peters S, Stevens J, et al. Addressing anxiety and fear during the female pelvic examination. J Prim Care Community Health. 2021;12:2150132721992195.","journal-title":"J Prim Care Community Health"},{"issue":"3","key":"938_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.amepre.2021.03.009","volume":"61","author":"CN Pinto","year":"2021","unstructured":"Pinto CN, Niles JK, Kaufman HW, Marlowe EM, Alagia DP, Chi G, et al. Impact of the COVID-19 pandemic on Chlamydia and Gonorrhea screening in the U.S. Am J Prev Med. 2021;61(3):386\u201393.","journal-title":"Am J Prev Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00938-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:08:33Z","timestamp":1671592113000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00938-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00938-y","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Ahvaz Jundishapur University of Medical Sciences approved the present study (Ref. ID: IR.AJUMS.REC.1399.141; Project number: 99s1). After explaining the objectives of the study and the method of interviewing to the participants and assuring them of the confidentiality of the data and their right to withdraw from the study at any point, informed written consent was obtained from the participants. By determining the time and place of the interview in advance, conditions were created for the participants to share their views and experiences at their convenience. Informed written consent was also obtained before the recording was activated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors listed have approved the manuscript to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report there are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}